Abbott Medical initiated a recall in July of 155,028 Proclaim and Infinity IPG models distributed in the US from 2015 through 2023 due to complaints from patients who are unable to exit the magnetic resonance imaging (MRI) mode.
The Food and Drug Administration has designated the recall class I, its most serious.